SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (936)11/2/2004 1:30:01 PM
From: tuck  Read Replies (1) | Respond to of 3557
 
[Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development]

FWIW, yet another research paper with no investment impact whatsoever from Yancopoulos and Co., an open access freebie:

pnas.org

Cheers, Tuck